P3 Health Partners Inc.
corporate_fare Company Profile
P3 Health Partners Inc. (NASDAQ:PIII) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for PIII at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for PIII spans 10-Q, 8-K, S-3, 4.
Recent high-impact activity:
- P3 Posts $30.8M Q3 Profit but Flags Going Concern and $15.2M Preferred Dividend Drain
- P3 Health Partners Posts $30.8M Q3 Net Income, Lifts FY26 Adjusted EBITDA Midpoint to $100M
- P3 Health Partners Posts $396M Q3 Revenue, $30.8M Net Income
- P3 Registers 15.6M CPF Warrant Shares for Resale; $167.9M Potential Exercise Proceeds
- P3 Health Partners Secures Up to $70M Financing from CPF Affiliates
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 13,705 shares in PIII as of the October 30, 2026 settlement, a 21.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 28.8% of PIII volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for PIII, detected from its recent SEC filings.
Resale Shelf Covers 15.6M Warrant Shares · Up to $167.9M in Potential Exercise Proceeds
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →